Results 41 to 50 of about 33,023 (303)
Arthritis &Rheumatology, EarlyView.Objective Eosinophilic granulomatosis with polyangiitis (EGPA) is a small vessel vasculitis characterized by eosinophilia, asthma, and ear, nose, and throat (ENT) involvement. Although glucocorticoids (GCs) are effective in controlling symptoms, relapses and GC dependence are common. The aim of this study was to develop predictive models for vasculitis
Matthias Papo +35 more
wiley +1 more source
Biologics in chronic urticaria
Allergologia et Immunopathologia, 2017 Chronic urticaria (CU) is defined as wheals, angioedema, or both, that last more than 6 weeks. Second-generation antihistamines are considered the first-line therapy for CU. Unfortunately, many patients will fail antihistamines and require alternative therapy, including immune response modifiers or biologics.
M, Ferrer, R, Madamba
openaire +4 more sources
Blood eosinophils and serum eosinophil cationic protein in patients with acute and chronic urticaria
Mediators of Inflammation, 1996 We have analysed the relationship of blood eosinophil count and serum eosinophil cationic protein (ECP) levels in patients with acute and chronic idiopathic urticaria.
G. Di Lorenzo +7 more
doaj +1 more source
The many faces of pediatric urticaria
Frontiers in Allergy, 2023 Urticaria is a common disease that can affect individuals of all age groups, with approximately one-quarter of the population experiencing it at least once in their lifetime.
Bulent Enis Sekerel +4 more
doaj +1 more source
EVALUATION OF CETIRIZINE HYDROCHLORIDE BASED FOR CHRONIC URTICARIA
, 2008 2008-08We investigated the suitability of cetirizine HCl (cetirizine) for the initial treatment of chronic urticaria. A secondary aim was to identify the optimal alternative treatments when switching from this drug to other drugs in patients who are ...
MORI, TAKAKO +12 more
core +1 more source
Strongyloidiasis and chronic urticaria [PDF]
Postgraduate Medical Journal, 1982 Summary Two patients with strongyloidiasis developed chronic urticaria. The cases provide support for inappropriate interactions of the effector mechanisms in helminthiasis resulting in urticaria in man.
openaire +2 more sources
Navigating adverse immunostimulation: A practical guide for clinical researchers
British Journal of Clinical Pharmacology, EarlyView.Problem Setting As drug development moves towards more complex products, early clinical development programmes are increasingly hampered by unwanted and/or unexpected activation of the immune system (adverse immune stimulation, AIS). Solution At the Centre for Human Drug Research, we have introduced standardized procedures to make AIS manageable, while
Juliette A. van den Noort +3 more
wiley +1 more source
Anais Brasileiros de Dermatologia, 2011 FUNDAMENTOS: A urticária crônica compromete o doente por interferir nas atividades diárias, prejudicar a autoestima e as relações interpessoais. Os profissionais de saúde subestimam seu impacto na qualidade de vida dos doentes.
Ana Paula Fusel de Ue +5 more
doaj +1 more source
Zafirlukast: Chronic Urticaria [PDF]
Hospital Pharmacy, 2015 This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration.
Joyce A, Generali, Dennis J, Cada
openaire +2 more sources
British Journal of Clinical Pharmacology, EarlyView.Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source